I forgot to add: Fx is the ratio of the change in secretory clearance to the change in GFR. When Fx = 1, tubular secretion declines proportionally to GFR (INH holds); when Fx < 1, secretion declines more than GFR would predict (INH fails).
24.01.2026 20:41 โ
๐ 0
๐ 0
๐ฌ 0
๐ 0
Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective
The role of membrane transporters on pharmacokinetics (PKs), drugโdrug interactions (DDIs), pharmacodynamics (PDs), and toxicity of drugs has been broadly recognized. However, our knowledge of modula....
๐ OAT1/3 substrates (anionic drugs) in severe CKD:
โ Fx = 0.50 ยฑ 0.29, CV = 58%
โ Penicillins, methotrexate, tenofovir
OCT2/MATE substrates (cationic drugs):
โ Fx โ 1.0 (range 0.77โ1.13)
โ Metformin, amantadine, trimethoprim
Anions are unpredictable, cations follow GFR ๐ฏ
๐ doi.org/10.1002/cpt....
24.01.2026 19:20 โ
๐ 3
๐ 1
๐ฌ 2
๐ 0
The Intact Nephron Hypothesis has guided renal drug dosing for 60+ years. The idea: as GFR drops, tubular secretion drops proportionally.
Sounds elegant, right?
But new data shows it's WRONG for many drugs in severe CKD.
Here's what you need to know ๐งต๐
#Nephrology #NephSky #Pharmacokinetics
24.01.2026 19:20 โ
๐ 4
๐ 0
๐ฌ 1
๐ 0
๐งต11/11
Source: Joshi A, et al. Sjรถgren's syndrome and hepatitis C virus infection presenting as hypokalemic quadriparesis: A case report. Journal of International Medical Research 2025;53(12):1-8. DOI: 10.1177/03000605251404767
21.12.2025 14:10 โ
๐ 1
๐ 1
๐ฌ 0
๐ 0
๐งต10/11
KEY LESSONS ๐ฏ:
1. Consider autoimmune diseases (especially Sjรถgren's) in refractory hypokalemia + distal RTA
2. Sicca symptoms may be subtle - ask specifically about them!
3. HCV can mimic Sjรถgren's - check viral load
4. Early diagnosis + electrolyte correction = rapid recovery
21.12.2025 14:10 โ
๐ 2
๐ 1
๐ฌ 1
๐ 0
๐งต9/11
TREATMENT:
โ
Sodium bicarbonate 1g BID
โ
Spironolacton 50mg daily
โ
Potassium chloride (oral)
OUTCOME:
Day 5: Patient could WALK! ๐
At discharge: Normal muscle strength in all limbs, normalized lab parameters. Complete recovery achieved!
21.12.2025 14:10 โ
๐ 1
๐ 0
๐ฌ 1
๐ 0
๐งต8/11
PATHOPHYSIOLOGY of distal RTA in Sjรถgren's:
Autoimmune attack โ absence of H+-ATPase pumps in intercalated cells โ can't excrete H+ into urine โ H+ retention โ metabolic acidosis with normal anion gap.
Increased urinary K+ loss โ severe hypokalemia โ quadriparesis ๐ช
21.12.2025 14:10 โ
๐ 2
๐ 0
๐ฌ 1
๐ 0
๐งต7/11
But wait - there's a twist! ๐ฎ
HCV antibody: POSITIVE
This created a diagnostic dilemma because chronic HCV infection can mimic primary Sjรถgren's syndrome with similar clinical & lab features.
Solution: HCV RNA PCR was ordered. It was NEGATIVE โ
This excluded active viral replication.
21.12.2025 14:10 โ
๐ 3
๐ 0
๐ฌ 1
๐ 0
a cat is being treated with a bottle of eye drops
ALT: a cat is being treated with a bottle of eye drops
๐งต6/11
What causes distal RTA in a young woman? ๐
Autoimmune workup showed:
ANA 97.2 AU/mL โ
SSA/Ro-52 antibodies +++
Directed history: She'd had DRY EYES for months ๐๏ธ
Schirmer's test: positive (severe bilateral dry eyes)
DIAGNOSIS: Primary Sjรถgren's syndrome with distal RTA!
21.12.2025 14:10 โ
๐ 1
๐ 0
๐ฌ 1
๐ 0
๐งต5/11
Muscle enzymes were dramatically elevated:
CK 36,614 IU/L โโโ
AST 348 U/L โโ
LDH 404 U/L โโ
Initially suggested inflammatory myopathy, BUT:
โ Acute onset (not gradual)
โ No rash
โ Enzymes normalized WITHOUT immunosuppression
Diagnosis: hypokalemia-induced rhabdomyolysis!
21.12.2025 14:10 โ
๐ 1
๐ 0
๐ฌ 1
๐ 0
Normal anion gap metabolic acidosis + positive urine anion gap = RENAL TUBULAR ACIDOSIS
But which type? Proximal vs distal?๐ค
Key findings that pointed to DISTAL RTA:
โ
Severe hypo-K
โ
Urine pH >5.5 despite systemic acidosis
โ
NO Fanconi syndrome features
www.kireportscommunity.org/post/renal-t...
21.12.2025 14:10 โ
๐ 1
๐ 0
๐ฌ 1
๐ 0
๐งต3/11
Despite adequate K+ and fluid replacement AND no more vomiting after antiemetics, potassium levels REMAINED critically low! ๐จ
This refractory hypokalemia suggested something more than just GI losses.
ABG was ordered and revealed:
pH 7.296 โ
HCO3- 14.4 mmol/L โ
Normal anion gap: 11
21.12.2025 14:10 โ
๐ 2
๐ 0
๐ฌ 1
๐ 0
๐งต2/11
Initial labs showed SEVERE electrolyte disturbances:
K+ 1.7 mmol/L โโ (critical!)
Na+ 130.1 mmol/L โ
Mg2+ 1.05 mg/dL โ
Working diagnosis: quadriparesis secondary to hypokalemia.
Treatment started: IV fluids, potassium supplementation, antiemetics.
But there was a problem...
21.12.2025 14:10 โ
๐ 1
๐ 0
๐ฌ 1
๐ 0
CASE REPORT: Hypokalemic Quadriparesis for Nephrologist
A woman in her mid-20s presented to the ER with sudden-onset weakness in all limbs, unable to stand from sitting position. She'd had lower abdominal pain, vomiting & leg muscle pain for one week.
What was causing this dramatic presentation? ๐งต
21.12.2025 14:10 โ
๐ 6
๐ 2
๐ฌ 2
๐ 0
Summary #GlomCon
23.09.2025 21:32 โ
๐ 5
๐ 1
๐ฌ 1
๐ 0
American Society of Nephrology Kidney Week 2025
Original Article | Nov. 7, 2025 | NEJM.org
Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis
Fig. 1A. A Serious Cardiovascular Events
The NEJM identity sits at the bottom.
In the PISCES trial involving participants receiving hemodialysis, fish oil (nโ3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: nej.md/49zWuqo
@asnkidney.bsky.social | #KidneyWk
07.11.2025 16:36 โ
๐ 25
๐ 11
๐ฌ 2
๐ 6
Empagliflozin, the kidney, and what we still donโt understand โ NephJC
NephJC short on an empagliflozin meta-analysis
The latest empadata dump: @nephroseeker.medsky.social writes up a #NephJC short on the meta analysis
www.nephjc.com/news/2025/10...
21.10.2025 00:03 โ
๐ 23
๐ 16
๐ฌ 2
๐ 0
Seeking collaboration with #MedLibs for scoping review on predictive models in peritoneal dialysis!
Protocol nearly finalized. Looking for expertise in search strategy peer-review (PRESS checklist) + optional database searches/deduplication.
DM if interested in co-authorship for this project!
20.08.2025 18:26 โ
๐ 1
๐ 0
๐ฌ 0
๐ 0
Lots of different ways to do observational causal inferenceโIV, proximal inference, etc. What if you could compare those strategies more directly?
New preprint w/ @melodyyhuang.bsky.social tries to do just that. Here's one cool figureโwe're able to visualize bias of 3 estimators on the same plot
01.08.2025 16:59 โ
๐ 22
๐ 7
๐ฌ 3
๐ 1
"It remains important to consider bromism in patients presenting with new neurologic, psychiatric, and/or dermatologic symptoms, as well as hyperchloremia
with a negative anion gap." (...) Elevated levels of halides such as bromide falsely increase chloride reading.
13.08.2025 14:46 โ
๐ 0
๐ 0
๐ฌ 0
๐ 0
Urine sodium (Urine Na) levels post-saline infusion in differentiating non-edematous hyponatremia ca. 2025
#Nephpearls #NephSky
๐๐ผ pubmed.ncbi.nlm.nih.gov/40775013/
10.08.2025 18:45 โ
๐ 8
๐ 2
๐ฌ 0
๐ 0
The Double-Icodextrin Dose Randomized Controlled Trial of a Double #Icodextrin Dose for #Older Patients on Incremental Continuous Ambulatory Peritoneal Dialysis #CAPD
#VisualAbstract by @md_abdulqader83
www.kireports.org/ar...
@lobbedezt.bsky.social @clemencebechade.bsky.social
18.07.2025 15:00 โ
๐ 14
๐ 7
๐ฌ 0
๐ 1
The "reproducibility crisis" in science constantly makes headlines. Repro efforts are often limited. What if you could assess reproducibility of an entire field?
That's what @brunolemaitre.bsky.social et al. have done. Fly immunity is highly replicable & offers lessons for #metascience
A ๐งต 1/n
10.07.2025 08:21 โ
๐ 318
๐ 173
๐ฌ 11
๐ 18
Using robcov() to adjust for donor-level clustering in kidney transplant outcomes?
I am doing a study to assess the association between transplant factors and kidney transplant outcomes (specifically survival of the transplanted kidney) using US registry data. Iโm using `cph()`.
A key issue is that when looking at outcomes, most recipients are not truly independent as they are clustered by donor. Specifically, in our analysis we have 57,153 donors where both kidneys were transplanted (into different recipients) and 39,389 donors where only one kidney was transplanted into a single recipient. So our analysis on recipient outcomes has n=153,695 recipients, and 96,542 donor clusters (each of which has either 1 or 2 recipients).
The focus of the research study is to assess if how the kidney was preserved impacts on kidney graft survival, and I adjust for several donor and recipient factors in the model.
This is how I am currently using robcov to get cluster robust SE (from which I am calculating 95% confidence intervals)
fit <- cph(Surv(time, event) ~ var1 + var2 + var3, data, x = TRUE, y = TRUE)
fit_robust <- robcov(fit, cluster = data$donor_id)
My understanding is that this uses the Huber-White method for updating the variance-covariance, which will increase the variance due to the clustering. Iโve seen other papers in the field use frailty terms (or other mixed effect models for non-survival outcomes). However, I think that robust SE using `robcov()` is probably a better solution here.
Is this a valid approach, given the large number of clusters, but small cluster size (either 2 or 1 per cluster)? Would the same approach be valid for logistic regression and linear (fit with `ols()`)?
06.07.2025 07:27 โ
๐ 1
๐ 1
๐ฌ 0
๐ 0
[Skim] KI-Tools fรผr die wissenschaftliche Literaturrecherche: Potenziale, Problematiken, Didaktik und Zukunftsperspektiven www.degruyterbrill.com/document/doi... - or AI Tools for Academic Literature Search: Possibilities, Problems, Didactics, and Future Prospects insanely comprehensive! (1)
06.07.2025 09:30 โ
๐ 6
๐ 5
๐ฌ 1
๐ 0
Next level of cherry-picking. Lack of significance in Student's t-test? Report then F-test and interpret it as a t-test ๐ซฃ๐ซฃ๐ซฃ
(F-test compares variances, not means๐คก)
Source: doi.org/10.3390/cell...
01.07.2025 18:29 โ
๐ 0
๐ 0
๐ฌ 0
๐ 0
Validate User
CLINICAL IMPACT:
Current CKD staging doesn't account for proximal tubular damage - a key risk factor for hypomagnesemia in CKD patients. ๐ Mg supplementation showed limited efficacy in proteinuric patients
Read more: doi.org/10.1093/ndt/...
๐งต3/3
21.06.2025 08:13 โ
๐ 3
๐ 0
๐ฌ 0
๐ 0